Home » Topics » Regulatory

Regulatory
RSS

Tracleer fails to meet primary endpoints in phase III CHF study

Feb. 12, 2002

No Comments

BMS and Sanofi-Synthelabo withdraw irbesartan sNDA

Feb. 8, 2002

No Comments

Xopenex approved for pediatric use in bronchospasm

Feb. 7, 2002

No Comments

Once-daily one-tablet formulation of Sustiva approved

Feb. 6, 2002

No Comments

First approval obtained for antihypertensive combination developed in Spain

Feb. 5, 2002

No Comments

Gleevec approved for gastrointestinal stromal tumors

Feb. 5, 2002

No Comments

Zometa receives positive opinion for treatment of cancer-related bone metastases

Feb. 4, 2002

No Comments

Amgen's Neulasta approved for febrile neutropenia

Feb. 4, 2002

No Comments

Guilford seeks expansion of indications for Gliadel in Europe

Feb. 4, 2002

No Comments

Approvable letter received for use of Altocor in hypercholesterolemia

Feb. 4, 2002

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

Tracleer fails to meet primary endpoints in phase III CHF study

BMS and Sanofi-Synthelabo withdraw irbesartan sNDA

Xopenex approved for pediatric use in bronchospasm

Once-daily one-tablet formulation of Sustiva approved

First approval obtained for antihypertensive combination developed in Spain

Gleevec approved for gastrointestinal stromal tumors

Zometa receives positive opinion for treatment of cancer-related bone metastases

Amgen's Neulasta approved for febrile neutropenia

Guilford seeks expansion of indications for Gliadel in Europe

Approvable letter received for use of Altocor in hypercholesterolemia

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Regulatory RSS

Regulatory
RSS